List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Gingivitis - Overview
Gingivitis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Gingivitis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Gingivitis - Companies Involved in Therapeutics Development
Amyndas Pharmaceuticals LLC
Avicanna Inc
TGV Laboratories Inc
Gingivitis - Drug Profiles
AMY-101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BLXA-4ME - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KSL-W - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Myc-102 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Agonise CB1 and CB2 for Gingivitis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gingivitis - Dormant Projects
Gingivitis - Product Development Milestones
Featured News & Press Releases
Aug 26, 2019: Amyndas Pharmaceuticals initiates phase 2a study of AMY-101 in adults with periodontal inflammation and gingivitis
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Gingivitis, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Gingivitis - Pipeline by Amyndas Pharmaceuticals LLC, H1 2020
Gingivitis - Pipeline by Avicanna Inc, H1 2020
Gingivitis - Pipeline by TGV Laboratories Inc, H1 2020
Gingivitis - Dormant Projects, H1 2020

List of Figures
Number of Products under Development for Gingivitis, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020

Companies Mentioned
• Amyndas Pharmaceuticals LLC
• Avicanna Inc
• TGV Laboratories Inc